**CRITERIA UNDER CMS REVIEW**

Similar documents
ANTICONVULSANTS. Details. Step Therapy Criteria Date Effective: April 1, 2019

ABILIFY INJ. Products Affected Step 2: ABILIFY MAINTENA PREFILLED SYRINGE 300 MG INTRAMUSCULAR ABILIFY MAINTENA PREFILLED SYRINGE 400 MG INTRAMUSCULAR

ANTIDEPRESSANTS. Details. Step Therapy 2018 Last Updated: 8/21/2018

ANTIDEPRESSANTS. Details. Step Therapy 2017 Last Updated: 5/23/2017

ARISTADA. Products Affected Step 2: ARISTADA PREFILLED SYRINGE 1064 MG/3.9ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 441 MG/1.

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

Step Therapy Medications

ANTICONVULSANTS. Details

ANTICONVULSANTS. Details

Santa Clara Family Health Plan Cal MediConnect Formulary. List of Step Therapy Requirements Effective: 12/01/ E

FirstCarolinaCare Insurance Company. Step Therapy Requirements

Granite Alliance Insurance Company (PDP) 2018 Step Therapy Criteria Last Updated: 10/23/18

Step Therapy Requirements. Effective: 1/1/2019

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

DIFICID. Products Affected Step 2: DIFICID TABLET 200 MG ORAL. Details

ANTICONVULSANTS. Details

ANTIDIABETIC AGENTS - MISCELLANEOUS

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 04/01/2019

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

Step Therapy Requirements

ANTIDIABETIC AGENTS - MISCELLANEOUS

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

ALLERGIC CONJUNCTIVITIS AGENTS

ANTICONVULSANTS. Details

ANTIDIABETIC AGENTS - MISCELLANEOUS

2015 Step Therapy Prior Authorization Medical Necessity Guidelines

2017 Step Therapy Criteria

Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO), Stride SM Value Rx Plus (HMO) and Stride SM Gain Rx (HMO)

CARE N CARE HEALTH PLAN

WELLCARE/ OHANA HEALTH PLAN 2015 STEP THERAPY CRITERIA (No Changes Made Since: 08/2015)

ANTIDEPRESSANTS. Details. dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet. Criteria

Step Therapy Requirements. Effective: 11/01/2018

Step Therapy Requirements. Effective: 05/01/2018

Simply Step Therapy Document September 2018 Y0114_18_33074_I_009

ADHD STIMULANTS-S(SHC)

HEALTHTEAM ADVANTAGE 2018 Step Therapy Criteria

Antipsychotics Prior Authorization Criteria for Louisiana Fee for Service and MCO Medicaid Recipients

HEALTHTEAM ADVANTAGE 2018 Step Therapy Criteria

ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY

Medicare Part D Drugs that Require Step Therapy Effective 12/01/2017

CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication.

CARE N CARE HEALTH PLAN

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

Step Therapy Group. Atypical Antipsychotic Agents

Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO) and Stride SM Value Rx Plus (HMO) Step Therapy Requirements

CARE N CARE HEALTH PLAN

Judges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children

2018 PDP Premier Step Therapy Document September 2018 Y0114_18_33144_I_009

Step Therapy Requirements. Effective: 03/01/2015

BRINTELLIX. Step Therapy Criteria HealthTeam Advantage Formulary ID: Version 6 Effective Date: 1/1/2016. PRODUCT(s) AFFECTED BRINTELLIX

JANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET BYDUREON BCISE 2 MG/0.

STEP THERAPY CRITERIA

Drugs requiring prior authorization: the list of drugs requiring prior authorization for this clinical criteria

ATYPICAL ANTIPSYCHOTICS

ANTICONVULSANT STEP THERAPY

Neighborhood Medicaid Formulary Changes: June 2017

2018 Step Therapy Criteria

Step Therapy Criteria

Formulary (Drug List)

Texas Prior Authorization Program Clinical Edit Criteria

CONTRAINDICATIONS TABLE

ANTICONVULSANT THERAPY

2017 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

U T I L I Z A T I O N E D I T S

ADHD STIMULANTS - SCORE

Relative Cost/Month. Less than $10. Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*

HEALTHTEAM ADVANTAGE PLAN 2017 Step Therapy Criteria Pending CMS Approval

Antipsychotic Medications Age and Step Therapy

Step Therapy Criteria 2019

2018 Step Therapy FID 18088

Acyclovir Ointment. Aetna Better Health Pennsylvania. Products Affected. acyclovir ointment 5 % external Details. Criteria

5-ASA. Products Affected DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED RELEASE. Details

5-ASA. Products Affected. Details. Dipentum 250 mg capsule. Lialda 1.2 gram tablet,delayed release

2019 Simply Step Therapy Document

Pharmacy Medical Necessity Guidelines: Antipsychotic Medications

TennCare Program TN MAC Price Change List As of: 03/30/2017

STEP THERAPY ALGORITHMS PUP Select Formulary

Y0133_StepTherapyCriteria _C 10/18/18 Y0133_StepTherapyCriteria _C es 10/18/18

2019 PDP Basic Step Therapy Document

TEST ANTICONVULSANT THERAPY. Products Affected. Step 2: Network Health Insurance Corporation NetworkCares Step Therapy Criteria Last Updated 11/2018

PPHP 2017 Formulary 2017 Step Therapy Criteria

ADHD STIMULANTS - SCORE

ACYCLOVIR OINT (CCHP2017)

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Farm Bureau Health Plans Date Effective: November 1, 2018.

ALPHA GLUCOSIDASE INHIBITOR THERAPY

Alprazolam 0.25mg, 0.5mg, 1mg tablets

Transcription:

**CRITERIA UNDER CMS REVIEW** ANTICONVULSANTS APTIOM TABLET 200 MG APTIOM TABLET 400 MG APTIOM TABLET 600 MG APTIOM TABLET 800 MG BANZEL SUSPENSION 40 MG/ML BANZEL TABLET 200 MG BANZEL TABLET 400 MG BRIVIACT SOLUTION 10 MG/ML BRIVIACT TABLET 10 MG BRIVIACT TABLET 100 MG BRIVIACT TABLET 25 MG BRIVIACT TABLET 50 MG BRIVIACT TABLET 75 MG CELONTIN CAPSULE 300 MG FYCOMPA SUSPENSION 0.5 MG/ML FYCOMPA TABLET 10 MG FYCOMPA TABLET 12 MG FYCOMPA TABLET 2 MG FYCOMPA TABLET 4 MG FYCOMPA TABLET 6 MG FYCOMPA TABLET 8 MG ONFI SUSPENSION 2.5 MG/ML ONFI TABLET 10 MG ONFI TABLET 20 MG PEGANONE TABLET 250 MG SPRITAM TABLET DISINTEGRATING SOLUBLE 1000 MG SPRITAM TABLET DISINTEGRATING SOLUBLE 250 MG SPRITAM TABLET DISINTEGRATING SOLUBLE 500 MG SPRITAM TABLET DISINTEGRATING SOLUBLE 750 MG VIMPAT SOLUTION 10 MG/ML VIMPAT TABLET 100 MG VIMPAT TABLET 150 MG VIMPAT TABLET 200 MG VIMPAT TABLET 50 MG Claim will pay automatically for Brand Anticonvulsants if enrollee has a paid claim for at least a 1 days supply of a Generic Anticonvulsant in the past 365 days. Otherwise, Brand Anticonvulsants require a step therapy exception request indicating: (1) history of inadequate treatment response with Generic Anticonvulsants, OR (2) history of adverse event with Generic Anticonvulsants, OR (3)Generic Anticonvulsants is contraindicated. 1

ANTIDEPRESSANTS amoxapine tablet 100 mg oral amoxapine tablet 150 mg oral amoxapine tablet 25 mg oral amoxapine tablet 50 mg oral citalopram hydrobromide solution 10 mg/5ml oral citalopram hydrobromide tablet 10 mg oral citalopram hydrobromide tablet 20 mg oral citalopram hydrobromide tablet 40 mg oral EMSAM PATCH 24 HOUR 12 MG/24HR TRANSDERMAL EMSAM PATCH 24 HOUR 6 MG/24HR TRANSDERMAL EMSAM PATCH 24 HOUR 9 MG/24HR TRANSDERMAL MARPLAN TABLET 10 MG VIIBRYD STARTER PACK KIT 10 & 20 MG VIIBRYD TABLET 10 MG VIIBRYD TABLET 20 MG VIIBRYD TABLET 40 MG Claim will pay automatically for Amoxapine, Citalopram, Emsam, Marplan or Vibryd if enrollee has a paid claim for at least a 1 days supply of a generic formulary antidepressant in the past 365 days. Otherwise, Amoxapine, Citalopram, Emsam, Marplan or Vibryd require a step therapy exception request indicating: (1) history of inadequate treatment response with Step 1 Antidepressant, OR (2) history of adverse event with Step 1 Antidepressant, OR (3)Step 1 Antidepressant is contraindicated. 2

ATYPICALS clozapine tablet 100 mg oral clozapine tablet 200 mg oral clozapine tablet dispersible 100 mg oral clozapine tablet dispersible 12.5 mg oral clozapine tablet dispersible 150 mg oral clozapine tablet dispersible 200 mg oral clozapine tablet dispersible 25 mg oral FANAPT TABLET 1 MG FANAPT TABLET 10 MG FANAPT TABLET 12 MG FANAPT TABLET 2 MG FANAPT TABLET 4 MG FANAPT TABLET 6 MG FANAPT TABLET 8 MG FANAPT TITRATION PACK TABLET 1 & 2 & 4 & 6 MG FAZACLO TABLET DISPERSIBLE 100 MG FAZACLO TABLET DISPERSIBLE 12.5 MG FAZACLO TABLET DISPERSIBLE 150 MG FAZACLO TABLET DISPERSIBLE 200 MG FAZACLO TABLET DISPERSIBLE 25 MG GEODON SOLUTION RECONSTITUTED 20 MG INTRAMUSCULAR NUPLAZID TABLET 17 MG SAPHRIS TABLET SUBLINGUAL 10 MG SUBLINGUAL SAPHRIS TABLET SUBLINGUAL 2.5 MG SUBLINGUAL SAPHRIS TABLET SUBLINGUAL 5 MG SUBLINGUAL VERSACLOZ SUSPENSION 50 MG/ML VRAYLAR CAPSULE 1.5 MG VRAYLAR CAPSULE 3 MG VRAYLAR CAPSULE 4.5 MG VRAYLAR CAPSULE 6 MG VRAYLAR CAPSULE THERAPY PACK 1.5 & 3 MG ZYPREXA RELPREVV SUSPENSION RECONSTITUTED 210 MG INTRAMUSCULAR Claim will pay automatically for Clozapine (Tabs or ODT), Fanapt, Fazaclo, Geodon inj, Nuplazid, Saphris, Versacloz, Vraylar, or ZYyprexa Relprevv if enrollee has a paid claim for at least a 1 days supply of 2 generic formulary atypicals in the past 365 days. Otherwise, Non-Preferred Antipsychotics require a step therapy exception request indicating any ONE of the following (1) Diagnosis that is not covered by generic formulary products (i.e. Acute treatment of agitation for Geodon injection), OR (2) History of inadequate treatment response with generic formulary products, OR (3) History of adverse event with generic formulary products, OR (4) Generic formulary products are contraindicated (5) Diagnosis that is not covered by Nuplazid (i.e. Parkinson's disease psychosis) 3

CELECOXIB celecoxib capsule 100 mg oral celecoxib capsule 200 mg oral celecoxib capsule 400 mg oral celecoxib capsule 50 mg oral Claim will pay automatically for Celecoxib if enrollee has a paid claim for at least a 1 days supply of a generic formulary NSAID in the member's overall utilization history (lifetime). Otherwise, Celecoxib requires a step therapy exception request indicating: (1) history of inadequate treatment response with any generic formulary NSAID, OR (2) history of adverse event with any generic formulary NSAID, OR (3) any generic formulary NSAID is contraindicated. 4

CNS STIMULANTS atomoxetine hcl capsule 10 mg oral atomoxetine hcl capsule 100 mg oral atomoxetine hcl capsule 18 mg oral atomoxetine hcl capsule 25 mg oral atomoxetine hcl capsule 40 mg oral atomoxetine hcl capsule 60 mg oral atomoxetine hcl capsule 80 mg oral Claim will pay automatically for ATOMOXETINE if enrollee has paid claims history for any one of the following formulary CNS stimulants: amphetamine salts, dexmethylphenidate, dextroamphetamine, methylphenidate OR guanfacine ER. Otherwise, ATOMOXETINE requires a step therapy exception request indicating: (1) history of inadequate treatment response with amphetamine salts, dexmethylphenidate, dextroamphetaminemethylphenidate, OR guanfacine ER OR (2) history of adverse event with amphetamine salts, dexmethylphenidate, dextroamphetamine, methylphenidate, OR guanfacine ER OR (3)amphetamine salts, dexmethylphenidate, dextroamphetamine, methylphenidate OR guanfacine ER is contraindicated. 5

ELIDEL ELIDEL CREAM 1 % EXTERNAL Claim will pay automatically for Elidel if enrollee has paid claims history for at least 2 different formulary topical steroids. 6

FENTANYL fentanyl patch 72 hour 100 mcg/hr fentanyl patch 72 hour 12 mcg/hr fentanyl patch 72 hour 25 mcg/hr fentanyl patch 72 hour 37.5 mcg/hr fentanyl patch 72 hour 50 mcg/hr fentanyl patch 72 hour 62.5 mcg/hr fentanyl patch 72 hour 75 mcg/hr fentanyl patch 72 hour 87.5 mcg/hr Claim will pay automatically for Fentanyl patches if enrollee has paid claims history of any 1 days supply in the past 365 days of Morphine ER, Methadone, morphine oral solution OR buprenorphine patches. Otherwise, the drug requires a step therapy exception request indicating any ONE of the following: (1) history of inadequate treatment response with Morphine ER, Methadone, morphine oral solution OR buprenorphine patches, OR (2) history of adverse event with Morphine ER, Methadone, morphine oral solution OR buprenorphine patches, OR (3) Morphine ER, Methadone, morphine oral solution OR buprenorphine patches are contraindicated. 7

PPI DEXILANT CAPSULE DELAYED RELEASE 30 MG DEXILANT CAPSULE DELAYED RELEASE 60 MG Claim will pay automatically for Dexilant if the enrollee has paid claims history of any 1 days supply of any single Step 1 agent in the member's overall utilization history (lifetime). Step 1 Drugs are: esomeprazole, omeprazole, pantoprazole. Otherwise, Dexilant requires a step therapy exception request indicating: (1) history of inadequate treatment response with Step 1 Drugs OR (2) history of adverse event with Step 1 Drugs OR (3) Step 1 Drugs are contraindicated 8

PROLIA PROLIA SOLUTION 60 MG/ML SUBCUTANEOUS Claim will pay automatically for Prolia if enrollee has a paid claim for at least a 1 days supply of Alendronate, Ibandronate or Risedroante in the past 365 days. Otherwise, Prolia requires a step therapy exception request indicating: (1) history of inadequate treatment response with Alendronate, Ibandronate or Risedroante, OR (2) history of adverse event with Alendronate, Ibandronate or Risedroante, OR (3) Alendronate, Ibandronate or Risedroante is contraindicated. 9

RANEXA RANEXA TABLET EXTENDED RELEASE 12 HOUR 1000 MG RANEXA TABLET EXTENDED RELEASE 12 HOUR 500 MG Claim will pay automatically for Ranexa if enrollee has a paid claim for at least a 1 day supply of Amlodipine, Atenolol, Diltiazem, Isosorbide dinitrate, Isosorbide mononitrate, Metoprolol ER, Minitran patch, Nadolol, Nicardipine, Nitroglycerin, Propranolol in the past 365 days. otherwise Ranexa requires a step therapy exception request indication any one of the following: (1) History of inadequate treatment response with step 1 agents or (2) History of adverse event with a step 1 agent or (3) Step 1 agents are contraindicated. 10

RYTARY RYTARY CAPSULE EXTENDED RELEASE 23.75-95 MG RYTARY CAPSULE EXTENDED RELEASE 36.25-145 MG RYTARY CAPSULE EXTENDED RELEASE 48.75-195 MG RYTARY CAPSULE EXTENDED RELEASE 61.25-245 MG Claim will pay automatically for Rytary if enrollee has a paid claim for at least a 1 days supply of generic Carbidopa/Levodopa in the member's overall utilization history (lifetime). Otherwise, Rytary requires a step therapy exception request indicating: (1) history of inadequate treatment response with Carbidopa/Levodopa, OR (2) history of adverse event with Carbidopa/Levodopa, OR (3) Carbidopa/Levodopa is contraindicated. 11

ULORIC ULORIC TABLET 40 MG ULORIC TABLET 80 MG Claim will pay automatically for Uloric if enrollee has a paid claim for at least a 1 days supply of Allopurinol in the past 365 days. Otherwise, Uloric requires a step therapy exception request indicating: (1) history of inadequate treatment response with Allopurinol, OR (2) history of adverse event with Allopurinol, OR (3) Allopurinol is contraindicated. 12

Index of Drugs/Alphabetical Listing A amoxapine tablet 100 mg oral... 2 amoxapine tablet 150 mg oral... 2 amoxapine tablet 25 mg oral... 2 amoxapine tablet 50 mg oral... 2 APTIOM TABLET 200 MG... 1 APTIOM TABLET 400 MG... 1 APTIOM TABLET 600 MG... 1 APTIOM TABLET 800 MG... 1 atomoxetine hcl capsule 10 mg oral... 5 atomoxetine hcl capsule 100 mg oral... 5 atomoxetine hcl capsule 18 mg oral... 5 atomoxetine hcl capsule 25 mg oral... 5 atomoxetine hcl capsule 40 mg oral... 5 atomoxetine hcl capsule 60 mg oral... 5 atomoxetine hcl capsule 80 mg oral... 5 B BANZEL SUSPENSION 40 MG/ML... 1 BANZEL TABLET 200 MG... 1 BANZEL TABLET 400 MG... 1 BRIVIACT SOLUTION 10 MG/ML... 1 BRIVIACT TABLET 10 MG... 1 BRIVIACT TABLET 100 MG... 1 BRIVIACT TABLET 25 MG... 1 BRIVIACT TABLET 50 MG... 1 BRIVIACT TABLET 75 MG... 1 C celecoxib capsule 100 mg oral... 4 celecoxib capsule 200 mg oral... 4 celecoxib capsule 400 mg oral... 4 celecoxib capsule 50 mg oral... 4 CELONTIN CAPSULE 300 MG... 1 citalopram hydrobromide solution 10 mg/5ml oral... 2 citalopram hydrobromide tablet 10 mg oral 2 citalopram hydrobromide tablet 20 mg oral 2 citalopram hydrobromide tablet 40 mg oral 2 clozapine tablet 100 mg oral... 3 clozapine tablet 200 mg oral... 3 clozapine tablet dispersible 100 mg oral... 3 clozapine tablet dispersible 12.5 mg oral... 3 clozapine tablet dispersible 150 mg oral... 3 clozapine tablet dispersible 200 mg oral... 3 clozapine tablet dispersible 25 mg oral... 3 D DEXILANT CAPSULE DELAYED RELEASE 30 MG... 8 DEXILANT CAPSULE DELAYED RELEASE 60 MG... 8 E ELIDEL CREAM 1 % EXTERNAL... 6 EMSAM PATCH 24 HOUR 12 MG/24HR TRANSDERMAL... 2 EMSAM PATCH 24 HOUR 6 MG/24HR TRANSDERMAL... 2 EMSAM PATCH 24 HOUR 9 MG/24HR TRANSDERMAL... 2 F FANAPT TABLET 1 MG... 3 FANAPT TABLET 10 MG... 3 FANAPT TABLET 12 MG... 3 FANAPT TABLET 2 MG... 3 FANAPT TABLET 4 MG... 3 FANAPT TABLET 6 MG... 3 FANAPT TABLET 8 MG... 3 FANAPT TITRATION PACK TABLET 1 & 2 & 4 & 6 MG... 3 FAZACLO TABLET DISPERSIBLE 100 MG... 3 FAZACLO TABLET DISPERSIBLE 12.5 MG... 3 FAZACLO TABLET DISPERSIBLE 150 MG... 3 FAZACLO TABLET DISPERSIBLE 200 MG... 3 FAZACLO TABLET DISPERSIBLE 25 MG... 3 fentanyl patch 72 hour 100 mcg/hr... 7 fentanyl patch 72 hour 12 mcg/hr... 7 fentanyl patch 72 hour 25 mcg/hr... 7 fentanyl patch 72 hour 37.5 mcg/hr... 7 13

fentanyl patch 72 hour 50 mcg/hr... 7 fentanyl patch 72 hour 62.5 mcg/hr... 7 fentanyl patch 72 hour 75 mcg/hr... 7 fentanyl patch 72 hour 87.5 mcg/hr... 7 FYCOMPA SUSPENSION 0.5 MG/ML... 1 FYCOMPA TABLET 10 MG... 1 FYCOMPA TABLET 12 MG... 1 FYCOMPA TABLET 2 MG... 1 FYCOMPA TABLET 4 MG... 1 FYCOMPA TABLET 6 MG... 1 FYCOMPA TABLET 8 MG... 1 G GEODON SOLUTION RECONSTITUTED 20 MG INTRAMUSCULAR... 3 M MARPLAN TABLET 10 MG... 2 N NUPLAZID TABLET 17 MG... 3 O ONFI SUSPENSION 2.5 MG/ML.. 1 ONFI TABLET 10 MG... 1 ONFI TABLET 20 MG... 1 P PEGANONE TABLET 250 MG... 1 PROLIA SOLUTION 60 MG/ML SUBCUTANEOUS... 9 R RANEXA TABLET EXTENDED RELEASE 12 HOUR 1000 MG 10 RANEXA TABLET EXTENDED RELEASE 12 HOUR 500 MG. 10 RYTARY CAPSULE EXTENDED RELEASE 23.75-95 MG... 11 RYTARY CAPSULE EXTENDED RELEASE 36.25-145 MG... 11 RYTARY CAPSULE EXTENDED RELEASE 48.75-195 MG... 11 RYTARY CAPSULE EXTENDED RELEASE 61.25-245 MG... 11 S SAPHRIS TABLET SUBLINGUAL 10 MG SUBLINGUAL... 3 SAPHRIS TABLET SUBLINGUAL 2.5 MG SUBLINGUAL... 3 SAPHRIS TABLET SUBLINGUAL 5 MG SUBLINGUAL... 3 SPRITAM TABLET DISINTEGRATING SOLUBLE 1000 MG... 1 SPRITAM TABLET DISINTEGRATING SOLUBLE 250 MG... 1 SPRITAM TABLET DISINTEGRATING SOLUBLE 500 MG... 1 SPRITAM TABLET DISINTEGRATING SOLUBLE 750 MG... 1 U ULORIC TABLET 40 MG... 12 ULORIC TABLET 80 MG... 12 V VERSACLOZ SUSPENSION 50 MG/ML... 3 VIIBRYD STARTER PACK KIT 10 & 20 MG... 2 VIIBRYD TABLET 10 MG... 2 VIIBRYD TABLET 20 MG... 2 VIIBRYD TABLET 40 MG... 2 VIMPAT SOLUTION 10 MG/ML. 1 VIMPAT TABLET 100 MG... 1 VIMPAT TABLET 150 MG... 1 VIMPAT TABLET 200 MG... 1 VIMPAT TABLET 50 MG... 1 VRAYLAR CAPSULE 1.5 MG... 3 VRAYLAR CAPSULE 3 MG... 3 VRAYLAR CAPSULE 4.5 MG... 3 VRAYLAR CAPSULE 6 MG... 3 VRAYLAR CAPSULE THERAPY PACK 1.5 & 3 MG... 3 Z ZYPREXA RELPREVV SUSPENSION RECONSTITUTED 210 MG INTRAMUSCULAR... 3 14